Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RAD 1901: Noninvasive Cardiac Radioablation for Ventricular Tachycardia Refractory to Medication and Catheter Ablation

NCT04757688 is registered in ClinicalTrials.gov with John Stahl as lead sponsor.

NCT NCT04757688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04757688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RAD 1901: Noninvasive Cardiac Radioablation for Ventricular Tachycardia Refractory to Medication and Catheter Ablation
Lead sponsor
John Stahl
Phase
Not applicable
Overall status
Withdrawn
Start date
November 30, 2022
Completion date
June 30, 2028
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ventricular tachycardia